Individuals Discontinuing Anti-Obesity Jabs Gain Back Pounds Far More Rapidly Compared to People Using Diet and Exercise

New research suggests that patients who come off new slimming jabs like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt conventional lifestyle programs.

Published data in a leading medical journal shows that while overweight people frequently drop substantial amounts of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month once they quit.

"People using these treatments need to be cognizant of the potential of fast weight regain when the medication concludes," warns lead investigator Dr. Susan Jebb.

Such speed of regain implies a return to original weight within about 18 months.

Analyzing Approaches

The analysis, which looked at dozens of studies involving thousands of participants, compared the results of GLP-1 agonists with conventional dieting.

The team emphasize that people who lose weight through lifestyle changes alone typically experience a slower creep back—perhaps 100 grams monthly—once they finish.

Understanding the Rapid Regain

Experts propose the way of the drugs is key to understanding the accelerated rebound.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which controls appetite.

"Artificially providing the hormone concentrations several times higher than the body's typical production could lead to the system to produce less of its own natural GLP-1, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.

"Stopping of this hormone supplement leads to appetite is unsuppressed, making excessive eating much more probable."

A Lifelong Disease?

Medical guidelines suggest the injections for people with weight-linked health risks, alongside prescribed lifestyle changes.

Professionals contend that, considering the significant potential of relapse, the treatment is often long-term.

This view is reinforced by drug manufacturers, who note that the findings "highlight the chronic nature of excess weight," similar to managing diseases like hypertension.

Patient Testimonies

Users who have come off the jabs report a sudden resurgence of cravings.

"It felt as if a switch that goes on and you're instantly starving," recalled a patient.

This challenge is exacerbated if users have not established lasting dietary or behavioural changes during treatment.

Significant Adoption

Survey data show that millions of people in the UK have tried weight-loss jabs in the last 12 months, with desire remaining high.

• Adoption is higher among females compared to men.
• The 40s and 50s age group shows the highest usage rates.
• Many access the medications through private healthcare rather than public health services.

Ultimately, researchers caution that while these medications are powerful tools for shedding pounds, they are not a magic solution and lasting health benefits likely depends on integrated behavioural management.